Biotech Values

[DewDiligence]

Update: I’ve just engaged in an offline exchange with the poster who questioned the SG brief on Twitter; my conclusion is that he doesn’t know what he’s talking about. (He was focused on whether AMPH infringes MNTA’s patent, which is a matter for the District Court—not the CAFC—to determine.)